- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 487/04 - Ortho-condensed systems
Patent holdings for IPC class C07D 487/04
Total number of patents in this class: 23029
10-year publication summary
|
1284
|
1391
|
1419
|
1493
|
1393
|
1490
|
1700
|
1621
|
1474
|
380
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4814 |
493 |
| F. Hoffmann-La Roche AG | 7832 |
361 |
| Janssen Pharmaceutica N.V. | 3245 |
316 |
| Hoffmann-La Roche Inc. | 3665 |
313 |
| Novartis AG | 10376 |
305 |
| Merck Sharp & Dohme LLC | 3702 |
302 |
| Gilead Sciences, Inc. | 2177 |
301 |
| Incyte Corporation | 1046 |
278 |
| Merck Patent GmbH | 5716 |
274 |
| Boehringer Ingelheim International GmbH | 4552 |
245 |
| Genentech, Inc. | 4052 |
212 |
| Dana-Farber Cancer Institute, Inc. | 2622 |
197 |
| Pfizer Inc. | 3353 |
185 |
| Takeda Pharmaceutical Company Limited | 2720 |
185 |
| AstraZeneca AB | 2845 |
164 |
| Incyte Holdings Corporation | 644 |
151 |
| Abbvie Inc. | 1841 |
126 |
| The Regents of the University of California | 20473 |
116 |
| LG Chem, Ltd. | 17805 |
114 |
| Merck Sharp & Dohme Corp. | 2185 |
114 |
| Other owners | 18277 |